The U.S. Food and Drug Administration
-
FDA approves leukemia drug of Agios Pharmaceuticals
Jul 22, 2018Agios Pharmaceuticals Inc said on Friday the U.S. Food and Drug Administration approved its treatment for a type of leukemia, the first targeted drug for patients with a specific genetic mutation. The company plans to launch... -
The U.S. Food and Drug Administration approved Novo Nordisk’s diabetes drug Ozempic
Dec 6, 2017Ozempic, known generically as semaglutide, will compete with others in a class known as glucagon-like peptide-1 (GLP-1) analogs, which imitate an intestinal hormone that stimulates the production of insulin. The U.S. Food and Drug Administration on... -
FDA approved a new indication for Victoza® to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes
Aug 31, 2017News Hour: The U.S. Food and Drug Administration (FDA) has approved a new indication for Victoza® (liraglutide) to reduce the risk of major adverse cardiovascular (CV) events in adults with type 2 diabetes and established CV... -
FDA expanded the use of Lynparza, sold by AstraZeneca Plc and Merck & Co Inc
Aug 18, 2017News Hour: The U.S. Food and Drug Administration on Thursday expanded the use of Lynparza, sold by AstraZeneca Plc and Merck & Co Inc, to include ongoing treatment of patients with recurrent ovarian cancer who have... -
Pfizer Inc’s process for manufacturing contaminated drugs at a plant Kansas was “out of control”, warns FDA
Mar 1, 2017News Hour: The U.S. Food and Drug Administration said Pfizer Inc’s process for manufacturing sterile injectable drugs at a plant in McPherson, Kansas was “out of control” and put patients at risk, according to a warning... -
The US FDA grants priority review to Novartis drug Zykadia
Feb 23, 2017News Hour: The U.S. Food and Drug Administration (FDA) has granted priority review to Novartis drug Zykadia as a first-line treatment for some lung cancer patients, the Swiss drugmaker said on Thursday. The priority review covers...
